Trial Outcomes & Findings for Combined Spinal-Epidural Temperature and Duration of Action (NCT NCT02020304)
NCT ID: NCT02020304
Last Updated: 2018-09-10
Results Overview
length of time in minutes the combined spinal epidural dose duration is calculated from the time of administration until the request is made for additional analgesia (\~1.5-3 hours) post dose. The subjects epidural is then dosed as per standard of care.
COMPLETED
PHASE2
58 participants
up to 3 hours
2018-09-10
Participant Flow
Participant milestones
| Measure |
Room Temperature
room temperature combined spinal epidural dose (60-75 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
Refrigerated Temperature
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
|---|---|---|
|
Overall Study
STARTED
|
30
|
28
|
|
Overall Study
COMPLETED
|
27
|
26
|
|
Overall Study
NOT COMPLETED
|
3
|
2
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Combined Spinal-Epidural Temperature and Duration of Action
Baseline characteristics by cohort
| Measure |
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
Total
n=53 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
27 Participants
n=5 Participants
|
26 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
27 Participants
n=5 Participants
|
26 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
27 participants
n=5 Participants
|
26 participants
n=7 Participants
|
53 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: up to 3 hourslength of time in minutes the combined spinal epidural dose duration is calculated from the time of administration until the request is made for additional analgesia (\~1.5-3 hours) post dose. The subjects epidural is then dosed as per standard of care.
Outcome measures
| Measure |
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
|---|---|---|
|
Time
|
74 minutes
Standard Deviation 29
|
81 minutes
Standard Deviation 32
|
SECONDARY outcome
Timeframe: from time of CSE administrationPopulation: number of subjects who achieved a VAS pain score of \</=3 at 5 minutes after CSE injection
Outcome measures
| Measure |
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
|---|---|---|
|
Analgesia Onset-5 Minutes Post Injection
|
24 Participants
|
14 Participants
|
SECONDARY outcome
Timeframe: up to 3 hoursPopulation: number of subjects who achieved a VAS pain score of \</= 3 at 10 minutes after CSE injection
Outcome measures
| Measure |
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
|---|---|---|
|
Analgesia Onset-10 Minutes Post Injection
|
25 Participants
|
19 Participants
|
SECONDARY outcome
Timeframe: up to 3 hoursPopulation: number of subjects who achieved a VAS pain score of \</= 3 at 15 minutes after injection
Outcome measures
| Measure |
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
|---|---|---|
|
Analgesia Onset-15 Minutes Post Injection
|
25 Participants
|
24 Participants
|
SECONDARY outcome
Timeframe: 30 minutespatients reporting pruritis at 30 minutes after CSE injection, self reported and measured on a scale of 0 (no itching at all) up to 10 (itching as bad as can be imagined)
Outcome measures
| Measure |
Room Temperature
n=27 Participants
room temperature combined spinal epidural dose (60-75 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
Refrigerated Temperature
n=26 Participants
refrigerated temperature combined spinal epidural dose (\~\<43 degrees F)
combined spinal epidural: Combined Spinal Epidural
|
|---|---|---|
|
Pruritus
|
2 units on a scale
Standard Deviation 1
|
1 units on a scale
Standard Deviation 2
|
Adverse Events
Room Temperature
Refrigerated Temperature
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place